Collaborative Model of Innovation

/ By / Innovation

It is interesting to see a rep from the worlds biggest patent filer (IBM) speak of open standards and a collaborative model of innovation. This FE piece states: “Given the complexity of our most pressing societal problems and the diversity of skills and resources required to solve them, innovation will increasingly require collaboration on a broader scale then ever before. Since innovation transcends the invention of new technologies— it is the application of these technologies to some useful purpose —it …

Collaborative Model of Innovation Read More »

ROCHE GETS FIRST PHARMA PRODUCT PATENT IN INDIA

/ By / Patent

The Financial Times reports: The Controller General of Patents last week granted the first product patent in pharmaceuticals to Roche India Pvt Ltd, the Indian arm of Swiss drugmaker F Hoffmann La Roche, for its biotech drug Pegasys (Peinterferon apha-2a), official sources told FE. ….The company had applied for the patent under the Mailbox facility for post-1995 inventions. Pegasys, a recombinant DNA technology drug, is one of the advanced drugs in the Interferon series of proteins, which has varied end …

ROCHE GETS FIRST PHARMA PRODUCT PATENT IN INDIA Read More »

FIRST MAILBOX OPPOSITION (GLEEVEC) DECIDED IN INDIA

/ By / Patent

The controversial Gleevec mailbox application has been decided, and not too surprisingly the decision went against Novartis. For those unfamiliar with the concept of a mailbox application, here is a short explanation from one of my articles: “India amended her patent regime in 1999 to provide that applications claiming pharmaceutical inventions would be accepted and put away in a mailbox, to be examined in 2005–these applications are commonly referred to as ‘mailbox applications’. This amendment was in pursuance of a …

FIRST MAILBOX OPPOSITION (GLEEVEC) DECIDED IN INDIA Read More »

RANBAXY LOSES LIPITOR IN FINLAND

/ By / Uncategorized

After the US and the UK, Ranbaxy suffers another patent defeat over multibillion dollar drug Lipitor in Finland. Like the US and the UK, it will appeal here as well. Thus far, its only victory has been in Austria. The Financial Express states: In another setback to India’s biggest drugmaker Ranbaxy Laboratories Ltd, a court in Finland has prohibited it from marketing its generic version of Pfizer’s cholesterol lowering drug Lipitor in the country.The Helsinki court of appeal in Finland …

RANBAXY LOSES LIPITOR IN FINLAND Read More »

Bird Flu Hits India

/ By / Patent

One of the first posts on this blog related to Avian Flu. Little did I know that I would have to post again–as the notorious bird flu makes it way to India. As expected, it has brought with it the patent controvery as well. A news item states: “The bird flu threat has become a litmus test for the government on how it would use the patent law flexibility to cope with a public health issue that could potentially be …

Bird Flu Hits India Read More »

CSIR and Ranbaxy among top PCT applicants

/ By / Patent

CSIR was always part of this list (taken from http://www.pharmabiz.com). Good to see that Ranbaxy features here too. It will be a while though before we catch up with South Korea which dominates here. “India stands third in the list of international patent applications filed by developing countries in 2005, and the Council of Scientific and Industrial Research (CSIR) and Ranbaxy Laboratories are among the top ten users of the PCT from developing countries. The top ten users of the …

CSIR and Ranbaxy among top PCT applicants Read More »

More GI registrations in India

/ By / Geographical Indication

A spate of new GI registrations in India. “The Geographical Indications Registry has granted GI certificate to Bidriware from Bidar, Channapatna toys and dolls, Nanjangud banana, Coorg orange, Mysore betel leaf, Mysore rosewood inlay, Mysore traditional paintings and Mysore agarbathi, thereby enabling producers and inventors to prevent others from exploiting their products without permission.” “We have accorded certificates to these items/products. The certificate owners will be the registered proprietors of the GI concerned,” an official with the Geographical Indications Registry …

More GI registrations in India Read More »

INDIA LAGS IN NUMBER OF IT PATENTS

/ By / Patent

An interesting piece (titled “India lags in number of IT patents”) on the low levels of software patents in India, despite India’s global excellence “India may be the world leader in information technology but it trails in a big way when it comes to patents in the IT sector. While the top 10 patents holders across the world are IT companies, in India, no IT firm has patents. The list of top 10 patents holders in India comprises only pharmaceutical …

INDIA LAGS IN NUMBER OF IT PATENTS Read More »

Government Babu Claiming Copyright??

/ By / Copyright

A very Happy New Year to all of you. Thought I would start 2006 with a news item that may bring a few laughs. The Economic Times asks: Should a government servant be awarded a copyright for drafting a document in the regular course of work and can he then charge a fee every time that document is used? Apparently, “the new Model Concession Agreement (MCA) for public-private partnership projects in the road sector has created history as well as …

Government Babu Claiming Copyright?? Read More »

A BUREAUCRATIC BABU AS IP CHIEF!!

/ By / Uncategorized

A good friend of mine, Syed Saif Mahmood (senior partner at Amicus Juris, New Delhi) wrote to inform me of a PIL (public interest litigation) that he filed to ensure that the scary prospect in the title (A bureaucratic babu as IP chief!!) does not translate to reality. This reminds me of another instance where the government wanted to appoint a bureacurat to head the competition commission. The Supreme Court came down heavily on the governments proposal and suggested that …

A BUREAUCRATIC BABU AS IP CHIEF!! Read More »

Scroll to Top